Results 11 to 20 of about 268,657 (221)

Pneumococcal vaccines in China. [PDF]

open access: yesHum Vaccin Immunother
Invasive pneumococcal disease (IPD) is a serious global public health problem and the leading cause of morbidity and mortality in children and adults in China. Thus, developing and administering pneumococcal vaccines are important for disease prevention.
Wang S   +6 more
europepmc   +5 more sources

Pneumococcal Vaccines

open access: yesMicrobiology Spectrum, 2019
Streptococcus pneumoniae is a Gram-Positive pathogen that is a major causative agent of pneumonia, otitis media, sepsis and meningitis across the world.
D. E. Briles   +4 more
doaj   +4 more sources

Should Pneumococcal Vaccines Eliminate Nasopharyngeal Colonization?

open access: yesmBio, 2016
Streptococcus pneumoniae remains an important human pathogen. For more than 100 years, there have been vaccine efforts to prevent pneumococcal infection. The pneumococcal conjugate vaccines have significantly reduced invasive disease.
Larry S. McDaniel, Edwin Swiatlo
doaj   +2 more sources

Next-Generation Whole-Cell Pneumococcal Vaccine [PDF]

open access: yesVaccines, 2019
Streptococcus pneumoniae remains a major public health hazard. Although Pneumococcal Conjugate Vaccines (PCVs) are available and have significantly reduced the rate of invasive pneumococcal diseases, there is still a need for new vaccines with unlimited ...
Victor Morais   +2 more
doaj   +2 more sources

Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly

open access: yesRisk Management and Healthcare Policy, 2018
Ger T Rijkers,1,2 Laura IE Yousif,1 Simone MC Spoorenberg,3 Frans J van Overveld1 1Department of Science, University College Roosevelt, Middelburg, the Netherlands; 2Department of Medical Microbiology and Immunology, St. Antonius Hospital ...
Rijkers GT   +3 more
doaj   +1 more source

Pneumococcal vaccine [PDF]

open access: yesPostgraduate Medical Journal, 1997
Summary Streptococcus pneumoniae is a frequent cause of pneumonia and meningitis. This article looks at the pneumococcal vaccine, its uses, efficacy, and adverse effects and how vaccination may be improved. We also look at the role of the new conjugate vaccines.
K L, Hattotuwa, C R, Hind
openaire   +2 more sources

The COVID-19 pandemic increased the demand for pneumococcal vaccination in Japan

open access: yesHuman Vaccines & Immunotherapeutics, 2021
Although routine vaccinations in children decreased during the coronavirus disease 2019 (COVID-19) pandemic, pneumococcal vaccine coverage in older adults has remained unknown.
Akira Komori   +2 more
doaj   +1 more source

Evaluation of a phased pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a study protocol for a prospective observational study and lessons learned

open access: yesBMC Public Health, 2019
Background Streptococcus pneumoniae causes substantial morbidity and mortality among children. The introduction of pneumococcal conjugate vaccines (PCV) has the potential to dramatically reduce disease burden.
S. F. La Vincente   +18 more
doaj   +1 more source

30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization

open access: yesVaccines, 2022
Pneumonia accounts for over 20% of deaths worldwide in children aged 1 to 5 years, disproportionately affecting lower- and middle-income countries.
Tianjing Hu   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy